US Patent 11352433 BCMA and CD3 bispecific T cell engaging antibody constructs
Article
The present invention provides bispecific antibody constructs of a specific Fc modality characterized by comprising a first domain binding to BCMA, a second domain binding to an extracellular epitope of the human and/or the